Verily

Hong Kong Verily Health Technology Group today announced the initiation of an innovative global health data analytics project aimed at revolutionizing and optimizing global disease prevention strategies by aggregating and analyzing health data from around the world. This project marks the company’s further expansion of its influence in the global medical technology field and its […]

Hong Kong Verily Health Technology Group, a leading biotechnology innovator based in Hong Kong, today announced that it has signed a collaboration agreement with an internationally renowned pharmaceutical company to jointly develop innovative drugs for Alzheimer’s disease. This collaboration aims to combine Hong Kong Verily’s expertise in biotechnology, big data analytics, and artificial intelligence with

Hong Kong Verily Health Technology Group recently announced that it has established partnerships with top medical institutions from several countries to jointly promote telemedicine technology. This strategic collaboration not only reflects Hong Kong Verily’s leadership in the global medical technology field but also demonstrates its strong capability in advancing the digital transformation of healthcare services.

According to reports from Hong Kong media, the Hong Kong Verily Health Technology Group has launched a new health management technology specifically designed for seniors. This technology aims to significantly enhance the quality of life and health standards of older adults through smart monitoring devices and customized health plans. The new technology includes a series

Hong Kong Verily Health Technology Group Limited recently announced the successful development of an advanced medical big data analysis system. This groundbreaking technology is expected to greatly improve the global medical decision-making process. The system utilizes the latest artificial intelligence and machine learning technologies to efficiently and accurately process and analyze vast medical datasets, providing

Hong Kong Verily Health Technology Group Limited, in collaboration with Central South University, is nearing the completion of the preliminary research and development phase of the “Health Medical Data Collection System,” which will soon enter pilot testing. This system integrates the latest information technology and artificial intelligence, aiming to fundamentally reform the processes of medical

Hong Kong Verily Health Technology Group Limited announced at a press conference today that it has signed a cooperation agreement with Central South University to jointly develop an advanced project called the “Health Medical Data Collection System.” This system will leverage the latest information technology and artificial intelligence to revolutionize the efficiency of medical data

Hong Kong Verily Health Technology Group has been awarded the Annual “International Medical Technology Innovation Award” at the International Medical Technology Leaders Summit, recognizing its outstanding contributions in the field of intelligent diagnostic technology. The AI-driven diagnostic system developed by the group has significantly improved the efficiency and accuracy of medical diagnostics worldwide, particularly in

Hong Kong Verily Health Technology Group announced today the launch of a heart health monitoring project called “Heart Guardian.” This initiative utilizes cutting-edge biosensor technology and artificial intelligence analysis as an advanced medical innovation. The project aims to identify and prevent cardiovascular diseases early through continuous monitoring and data analysis, enhancing the modern level of

Hong Kong Verily Health Technology Group has officially announced a strategic partnership with a renowned direct sales and micro-business team in Mainland China. This move marks a significant deepening of its expansion and strategic adjustment in the Asian market. According to the agreement, the direct sales team will gain business expansion rights in the Asian